Current advances in separation chemistry for antibody purification and analysis
Analytical Sciences · 2025-05 · 41 (5) · 653-666
DOI: 10.1007/s44211-025-00748-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Analytical Sciences, online erschienen am 24.03.2025. Verfasst von Suprit Deol und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Kanagawa, 2238522, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 112 Literaturangaben. Gefördert von: Keio Leading-edge Laboratory of Science and Technology.
Abstract (Originalsprache)
Monoclonal antibodies (mAbs) have become essential in modern therapeutics, offering high specificity and efficacy in treating diseases such as cancer, autoimmune disorders, and infectious diseases. With the increasing demand for mAbs, robust analytical and purification technologies are critical to ensuring their safety, efficacy, and consistency. This review highlights recent advances in the application of HPLC for both mAb analysis and purification. In the analytical domain, techniques such as size exclusion chromatography (SEC), hydrophobic interaction chromatography (HIC), ion exchange chromatography (IEX), and reversed-phase chromatography (RPLC) are explored for their role in evaluating mAb structural attributes and post-translational modifications (PTMs). These methods are indispensable for ensuring stability and functionality while meeting stringent regulatory requirements. In the context of purification, Protein A affinity chromatography remains the gold standard for initial capture of mAb; however, challenges such as high cost and harsh elution conditions have prompted the development of alternative purification technologies. IEX, HIC, multimodal, and membrane chromatography are also critical in achieving high-purity mAb products through multistep workflows, including intermediate purification and polishing stages. This review emphasizes the central role of HPLC in addressing the complex challenges of mAb manufacturing and characterization. By integrating established and emerging chromatographic techniques, it provides insights into the future directions of therapeutic antibody development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Kanagawa, 2238522, Japan.
- Exelixis., Inc., 1851 Harbor Bay Parkway, Alameda, CA, 94502, USA.
- Exelixis., Inc., 1851 Harbor Bay Parkway, Alameda, CA, 94502, USA. ymatsuda@exelixis.com.
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Kanagawa, 2238522, Japan. hiruta@applc.keio.ac.jp.
Förderung
- Keio Leading-edge Laboratory of Science and Technology
Zitieren
APA
Deol, S., Matsuda, Y., & Hiruta, Y. (2025). Current advances in separation chemistry for antibody purification and analysis. Analytical Sciences, 41(5), 653-666. https://doi.org/10.1007/s44211-025-00748-2
Vancouver
Deol S, Matsuda Y, Hiruta Y. Current advances in separation chemistry for antibody purification and analysis. Analytical Sciences. 2025;41(5):653-666. doi:10.1007/s44211-025-00748-2
BibTeX
@article{Deol2025,
author = {Deol, Suprit and Matsuda, Yutaka and Hiruta, Yuki},
title = {Current advances in separation chemistry for antibody purification and analysis},
journal = {Analytical Sciences},
year = {2025},
volume = {41},
number = {5},
pages = {653--666},
doi = {10.1007/s44211-025-00748-2}
}
EUVIMED